CR Double-Crane announces RMB 0.10 per share cash dividend

China Resources Double-Crane Pharmaceutical Co., Ltd. has announced a cash dividend of RMB 0.10 per share for the first half of 2025. This distribution is based on the company's total share capital of 1,038,757,509 shares, resulting in a total cash dividend of RMB 103,875,750.90. The profit distribution plan was approved at the company's second extraordinary general meeting on September 9, 2025.

The equity registration date for A-share holders is October 27, 2025, with the ex-dividend date and cash dividend payment date both set for October 28, 2025. Dividends will be disbursed via China Securities Depository and Clearing Corporation Limited Shanghai Branch for most shareholders, while the company's controlling shareholder, Beijing Pharmaceutical Group Co., Ltd., will receive its cash dividend directly from the company.

Tax implications vary for different investor types. Natural person shareholders and investment funds holding the company's shares for over one year are exempt from individual income tax on the dividend. For holdings of one year or less, a 20% tax applies for holdings under one month, and a 10% tax for holdings between one month and one year. Qualified Foreign Institutional Investors (QFIIs) will have a 10% enterprise income tax withheld, resulting in a net cash dividend of RMB 0.09 per share.